drugset
drugset / Trial / NCT04828824

Premature Discontinuation of Contraceptive Implants

NCT04828824 ↗

Phase 4 Completed 600 enrolled University of Colorado, Denver
RandomizedParallel-groupOpen-labelTreatment

Summary

To compare rates of etonogestrel implant discontinuation in implant initiators who are given advance provision of combined oral contraceptive pills (COCs) and a bleeding rescue regimen (COCR intervention) to participants given standard counseling (comparator).

Timeline

Start
2021-06-18
Primary completion
2025-11-12
Completion
2025-11-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Norgestimate Small molecule — Oral
Subject ethinyl estradiol Small molecule 35 ug Oral

Indications

No indication recorded.